Reference
Reference
Ragaz J, Spinelli JJ. Outcome of breast cancer therapies for adjuvant versus advanced disease: how much do they differ? Critical comments towards the present process of randomized trials as a pre-requisite for adjuvant therapy guidelines [abstract no. 14]. Breast Cancer Res Treat 2007 Dec; 106 Suppl. 1: 6 (plus oral presentation)
References
Health Canada. Confidentiality arrangements — authorisation and safety of medicines — European Commission (EC), European Medicines Agency (EMEA), and Health Products and Food Branch (HPFB), Health Canada [online]. Available from URL: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/activit/int/ec_emea_let_e.html [Accessed 2008 Jan 16]
European Medicines Agency. Closer ties on medicines safety between European and Canadian regulatory authorities. Media Release [online]. Available from http://emea.europa.eu/pdfs/general/direct/pr/EU-Canada_confidentiality.pdf [Accessed 2008 Jan 16]
Reference
The procedure for the ethical review of protocols for clinical research projects in the European Union. Int J Pharm Med 2007; 21 (1): 1–113
Reference
Evans JP. Health care in the age of genetic medicine. JAMA 2007 Dec 12; 298 (22): 2670–2
References
Tatsioni A, Bonitsis NG, Ioannidis JP. Persistence of contradicted claims in the literature. JAMA 2007 Dec 5; 298 (21): 2517–26
Avorn J. In defense of pharmacoepidemiology: embracing the Yin and Yang of drug research. N Engl J Med 2007 Nov 29; 357 (22): 2219–21
References
Yank V. Financial ties and concordance between results and conclusions in metaespecially analyses: retrospective cohort study. BMJ 2007 Dec 6; 335 (7631). Epub ahead of print
Epstein RA. Influence of pharmaceutical funding on the conclusions of meta-analyses: original data are sound, but conclusions should be interpreted with caution. BMJ 2007 Dec 8; 335 (7631): 1167
Reference
Royal College of Physicians. Guidelines on the practice of ethics committees in medical research with human participants [online]. Available from URL: http://www.rcplondon.ac.uk/pubs [Accessed 2008 Jan 14]
Reference
Collier J. Parliamentary review asks NICE to do better still: out goes the arbitrary funding threshold: in come NICE directives. BMJ 2008 Jan 12; 336 (7635): 56–7
Reference
Jack A. Bitter pills. BMJ 2007 Dec 1; 335 (7630): 1120–1
Rights and permissions
About this article
Cite this article
Forum. Pharm Med 22, 55–58 (2008). https://doi.org/10.1007/BF03256683
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256683